Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2022 | Story Leonie Bolleurs | Photo Leonie Bolleurs
Dr Karen Venter
Dr Venter received her PhD at the December graduation ceremonies. She focused on addressing societal challenges through the practice of engaged scholarship in community-university research partnerships for the common good.

When asked what inspired her to pursue a PhD, Dr Karen Venter, Head of the Division of Service Learning in the Directorate Community Engagement at the University of the Free State (UFS), said she wanted to make a difference in addressing societal challenges through the practice of engaged scholarship in community-university research partnerships for the common good. 

“Also, I love to learn and share knowledge – and that is exactly what I did in this PhD, titled: An integrated service-learning praxis approach for flourishment of professional development in community-higher education partnerships.” 

She explains, “My five-articles-style thesis explored the contribution of an integrated service-learning praxis approach towards the flourishment of engaged scholarship in community-higher education partnerships. The approach combined community engaged service-learning (CESL), appreciative inquiry and appreciative leadership, to advance the praxis of engaged scholarship. The study was demarcated in the field of higher education, applied in the discipline of nursing education, and contextually bound to three interrelated action research cycles and settings – for international, national, and local level engagement.”

Community members participate in the research journey

“The intent of the study was to recognise the community-led action learning of community member participants at the core action learning set,” says Dr Venter. 

The study followed a participatory action learning and action research methodology. During her research journey, she was joined by members of the community, specifically from Bloemshelter – a shelter for the homeless. “They co-constructed and completed a four-year community-led action learning pathway to holistic development (spiritual, personal, professional), which brought about holistic social change and well-being in their livelihood, moving from dependence on others to establishing viable multiple micro-enterprises,” she says.

The UFS affiliated with GULL to reward the community member participants’ action learning. “Already in 2019, GULL certified their action learning with a Professional Bachelor’s degree, while I still had to document the action research, and only now received the PhD,” says Dr Venter. 

“I am grateful to all the participants who co-created action-oriented knowledge with me in the study, from international, to national, to local level of engagement.”

Integrating a PhD with work and life

A PhD requires a lot of hard work and effort, to the point that the lines between studies, work, and life become blurred. Dr Venter acknowledged that she tried to balance work/life and study, but “I was not very good at it”. 
Passion, patience, peace, perseverance, positivity, and prayer are good principles to maintain when you are in the process of completing a PhD. – Dr Karen Venter 

She elaborates, “Studying became an integrated part of my work and life.  For the duration of my studies, I started working at 03:00 and I also did not watch any television.” She did, however, make time for herself by joining the wellness workout programme presented by the UFS, enjoyed gardening, and playing with her grandchildren. “I also tried to rest one day over weekends, and made time to praise and worship, which energised me for the next week,” she adds. 

“Passion, patience, peace, perseverance, positivity, and prayer are good principles to maintain when you are in the process of completing a PhD, she believes. 

Dr Venter says that although writing a PhD is indeed lonely, it is also an exciting journey, “especially when you reach those moments of breakthrough that can only come to life after deep reflection.” She also describes it as a deep spiritual journey. “Almost like walking in and out of a labyrinth – and where many hours become equal to a breath.

She is very grateful to her supervisors, Dr Somarie Holtzhausen, Prof Mabel Erasmus, and Dr Elanie Myburgh. “I deeply honour and salute you for your unconditional and continuous coaching, compassion, and care – guiding, supporting, motivating, mentoring, and keeping me grounded until I completed the journey.”

 

 


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept